METROPOLITAN LIFE INSURANCE CO/NY - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 97 filers reported holding G1 THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.35 and the average weighting 0.0%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$20,740
-70.4%
2,729
-60.3%
0.00%0.0%
Q4 2021$70,102
-38.1%
6,866
-18.7%
0.00%
-50.0%
Q3 2021$113,292
-53.4%
8,442
-23.9%
0.00%
-33.3%
Q2 2021$243,249
-8.8%
11,0870.0%0.00%
-25.0%
Q1 2021$266,753
+33.7%
11,0870.0%0.00%
+33.3%
Q4 2020$199,455
+55.8%
11,0870.0%0.00%
+50.0%
Q3 2020$128,055
-52.4%
11,0870.0%0.00%
-60.0%
Q2 2020$268,971
+120.1%
11,0870.0%0.01%
+66.7%
Q1 2020$122,179
-58.3%
11,0870.0%0.00%
-40.0%
Q4 2019$293,029
+10.9%
11,087
-4.4%
0.01%
+25.0%
Q3 2019$264,248
+12.4%
11,600
+51.3%
0.00%0.0%
Q2 2019$235,009
+84.7%
7,6650.0%0.00%
+100.0%
Q1 2019$127,239
-13.3%
7,6650.0%0.00%
-33.3%
Q4 2018$146,785
-58.8%
7,665
+12.4%
0.00%
-50.0%
Q3 2018$356,513
-99.9%
6,8180.0%0.01%
+20.0%
Q2 2018$296,311,000
+74.1%
6,818
+48.4%
0.01%
+150.0%
Q1 2018$170,207,0004,5940.00%
Other shareholders
G1 THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 719,985$31,291,0002.32%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 72,000$3,121,0001.20%
EMERALD ADVISERS, LLC 506,424$22,009,0000.83%
Virtus ETF Advisers LLC 18,103$787,0000.70%
Birchview Capital, LP 22,000$956,0000.65%
EMERALD MUTUAL FUND ADVISERS TRUST 352,053$15,300,0000.55%
Hillhouse Capital Management 699,431$30,397,0000.52%
Rock Springs Capital Management LP 300,000$13,038,0000.50%
BB BIOTECH AG 352,607$15,324,0000.44%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 287,000$12,473,0000.44%
View complete list of G1 THERAPEUTICS INC shareholders